I am dying of squamous cell carcinoma, and potential treatments are out of reach
There&#x27;s a very easy regulatory solution:  Roll the drug approval process back to the way things were done prior to 1962.  Back then, safety testing was all that was required.  Efficacy testing -- which is difficult, expensive, arguably unethical in itself, and in some cases effectively impossible -- was not required.  Drugs cost ~20-50x less to bring to market, and were brought to market faster.  Indeed the 40s and 50s are still known as the pharmaceutical industry&#x27;s &quot;Golden Age.&quot;  And it wasn&#x27;t only because of low-hanging fruit.<p>Pair this paradigm with extensive postmarketing surveillance and periodic reviews for efficacy in a patient population.  These could be done at two years, five years, and eight years -- and approval automatically rescinded if safety issues arise or efficacy is close to null.<p>Give people with fatal diseases a &quot;right to try&quot; drugs that haven&#x27;t passed safety testing -- and use that data.<p>Ban drug advertising in public-facing media.<p>Simple as.